BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 28830873)

  • 1. Vasectomy and Risk of Prostate Cancer in a Screening Trial.
    Shoag J; Savenkov O; Christos PJ; Mittal S; Halpern JA; Askin G; Shoag D; Golan R; Lee DJ; O'Malley P; Najari B; Eisner B; Hu JC; Scherr D; Schlegel P; Barbieri CE
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1653-1659. PubMed ID: 28830873
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Black A; Parnes HL; Grubb R; David Crawford E; Miller A; Reding D; Andriole G
    Cancer Epidemiol; 2012 Dec; 36(6):e401-6. PubMed ID: 23000116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC).
    Smith K; Byrne ; Castaño JM; Chirlaque MD; Lilja H; Agudo A; Ardanaz E; Rodríguez-Barranco M; Boeing H; Kaaks R; Khaw KT; Larrañaga N; Navarro C; Olsen A; Overvad K; Perez-Cornago A; Rohrmann S; Sánchez MJ; Tjønneland A; Tsilidis KK; Johansson M; Riboli E; Key TJ; Travis RC
    J Clin Oncol; 2017 Apr; 35(12):1297-1303. PubMed ID: 28375714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasectomy and the risk of prostate cancer.
    Holt SK; Salinas CA; Stanford JL
    J Urol; 2008 Dec; 180(6):2565-7; discussion 2567-8. PubMed ID: 18930503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
    Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
    Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
    Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
    Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
    Tsodikov A; Gulati R; Heijnsdijk EAM; Pinsky PF; Moss SM; Qiu S; de Carvalho TM; Hugosson J; Berg CD; Auvinen A; Andriole GL; Roobol MJ; Crawford ED; Nelen V; Kwiatkowski M; Zappa M; Luján M; Villers A; Feuer EJ; de Koning HJ; Mariotto AB; Etzioni R
    Ann Intern Med; 2017 Oct; 167(7):449-455. PubMed ID: 28869989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Use and Mortality in Two Contemporary US Cohorts.
    Huang WY; Daugherty SE; Shiels MS; Purdue MP; Freedman ND; Abnet CC; Hollenbeck AR; Hayes RB; Silverman DT; Berndt SI
    Epidemiology; 2018 Jan; 29(1):126-133. PubMed ID: 28863047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasectomy and cardiovascular disease risk: A systematic review and meta-analysis.
    Guo ZL; Xu JL; Lai RK; Wang SS
    Medicine (Baltimore); 2017 Aug; 96(34):e7852. PubMed ID: 28834896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.
    Alshalalfa M; Verhaegh GW; Gibb EA; Santiago-Jiménez M; Erho N; Jordan J; Yousefi K; Lam LLC; Kolisnik T; Chelissery J; Seiler R; Ross AE; Karnes RJ; Schaeffer EM; Lotan TT; Den RB; Freedland SJ; Davicioni E; Klein EA; Schalken JA
    Oncotarget; 2017 Aug; 8(31):50804-50813. PubMed ID: 28881605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
    Felker ER; Raman SS; Margolis DJ; Lu DSK; Shaheen N; Natarajan S; Sharma D; Huang J; Dorey F; Marks LS
    AJR Am J Roentgenol; 2017 Dec; 209(6):1272-1277. PubMed ID: 28858541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
    Hendriks RJ; van der Leest MMG; Dijkstra S; Barentsz JO; Van Criekinge W; Hulsbergen-van de Kaa CA; Schalken JA; Mulders PFA; van Oort IM
    Prostate; 2017 Oct; 77(14):1401-1407. PubMed ID: 28853167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Population-based Prostate-specific Antigen Screening Beginning at Age 40.
    Weight CJ; Narayan VM; Smith D; Kim SP; Karnes RJ
    Urology; 2017 Dec; 110():127-133. PubMed ID: 28842211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial.
    Stamm AW; Banerji JS; Wolff EM; Slee A; Akapame S; Dahl K; Massman I I I JD; Soung MC; Pittenger KR; Corman JM
    Can J Urol; 2017 Aug; 24(4):8910-8917. PubMed ID: 28832310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasectomy and Prostate Cancer Risk: A 38-Year Nationwide Cohort Study.
    Husby A; Wohlfahrt J; Melbye M
    J Natl Cancer Inst; 2020 Jan; 112(1):71-77. PubMed ID: 31119294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasectomy and the risk of prostate cancer in a prospective US Cohort: Data from the NIH-AARP Diet and Health Study.
    Davenport MT; Zhang CA; Leppert JT; Brooks JD; Eisenberg ML
    Andrology; 2019 Mar; 7(2):178-183. PubMed ID: 30714352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort.
    Seikkula H; Kaipia A; Hirvonen E; Rantanen M; Pitkäniemi J; Malila N; Boström PJ
    Cancer Epidemiol; 2020 Feb; 64():101631. PubMed ID: 31760357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between vasectomy and risk of testicular cancer: A systematic review and meta-analysis.
    Duan H; Deng T; Chen Y; Zhao Z; Wen Y; Chen Y; Li X; Zeng G
    PLoS One; 2018; 13(3):e0194606. PubMed ID: 29566037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Vasectomy on the Development and Progression of Prostate Cancer: Preclinical Evidence.
    Kawahara T; Teramoto Y; Li Y; Ishiguro H; Gordetsky J; Yang Z; Miyamoto H
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Vasectomy Complications and Safety Concerns.
    Yang F; Li J; Dong L; Tan K; Huang X; Zhang P; Liu X; Chang D; Yu X
    World J Mens Health; 2021 Jul; 39(3):406-418. PubMed ID: 32777870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.